Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Better Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023


Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, today announced it will release its third quarter 2023 financial results before the market opens on Thursday, November 09, 2023. Management will host a conference call and webcast to provide a business update at 8:30 a.m. ET / 5:30 a.m. PT on Thursday, November 09, 2023.

To access the conference call, please register at: https://register.vevent.com/register/BI7ccccb1e37c44102b4f5ce26d785604d. Upon registering, each participant will be provided with call details and access codes. All participants are encouraged to join 10 minutes prior to the start time. The live webcast may be accessed by visiting the event link at: https://edge.media-server.com/mmc/p/dk6kxzaw. A replay of the webcast may be accessed from the Presentations & Events page in the Investors section of the Better Therapeutics corporate website at: https://investors.bettertx.com.

About Better Therapeutics

Better Therapeutics is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address underlying factors that sustain or worsen cardiometabolic diseases. The Company has developed a proprietary platform for the development of FDA-regulated, software-based solutions and in July 2023 received FDA authorization for AspyreRxTM to treat adults with type 2 diabetes. The CBT delivered by Better Therapeutics' PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics' clinically validated mobile applications are intended to be prescribed by physicians and reimbursed like traditional medicines.

For more information visit: bettertx.com and aspyrerx.com.


These press releases may also interest you

at 17:50
Feminine Hygiene Wash Market size is set to grow by USD 124.8 million from 2024-2028, Advertising and promotion of feminine hygiene wash products to boost the market growth, Technavio
The global feminine hygiene wash market  size is estimated to grow by USD 124.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 5.17%  during the forecast period.  Advertising and promotion of...

at 17:45
Cinnamon Market size is set to grow by USD 412.9 million from 2024-2028, Rising awareness about health benefits of cinnamon to boost the market growth, Technavio
The global cinnamon market size is estimated to grow by USD 412.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about 7.97% during the forecast period. Rising awareness about health benefits of cinnamon...

at 17:35
Mixed Martial Arts Equipment Market size is set to grow by USD 252.6 million from 2024-2028, Growing popularity of women's MMA to boost the market growth, Technavio
The global mixed martial arts equipment market size is estimated to grow by USD 252.6 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 4.57% during the forecast period. Growing popularity of women's mma is...

at 17:31
BCG Unresponsive NMIBC Market to Register Sustainable Growth During the Study Period (2020-2034) | DelveInsight
DelveInsight's BCG Unresponsive NMIBC Market Insights report includes a comprehensive understanding of current treatment practices, BCG unresponsive NMIBC emerging drugs, market share of individual therapies, and current and...

at 17:15
The Inner Circle acknowledges, Sharon E. Oster, MD as a Pinnacle Lifetime Member
Prominently featured in The Inner Circle, Sharon E. Oster, MD, is acknowledged as a Pinnacle Life Member for her contributions to the fields of Internal Medicine and Infectious Diseases. Dr. Oster began her scholarship at the University of Colorado...

at 17:10
Aronia Berries Market size is set to grow by USD 501.5 million from 2024-2028, Health benefits of aronia berries boost the market, Technavio
The global aronia berries market size is estimated to grow by USD 501.5 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 9.64% during the forecast period. Health benefits of aronia berries is driving...

More news about Health...


News published on and distributed by: